Organization Overview
Alternative names
amphotericin b (fungizone) (1995)
cysteamine (cystagon) (2012)
elapegademase-lvlr (revcovi) (2018 NDA)
levocarnitine (carnitor) (1985 NDA)
pegademase-bovine (Adagen) (1990 NDA)
pegaspargase (oncaspar) (1994 NDA)
procarbazine (matulane) (1969 NDA)
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (1 trial)
dacarbazine (dtic-dome) (1 trial)
Atrophy (Phase 2)
Breast Neoplasms (Phase 2)
Colitis (Phase 3)
Colitis, Ulcerative (Phase 3)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Digestive System Neoplasms (Phase 1)
Distal Myopathies (Phase 2)
Enterocolitis (Phase 2)
Enterocolitis, Necrotizing (Phase 2)
Essential Hypertension (Phase 2)
Fatigue (Phase 2)
Gastrointestinal Neoplasms (Phase 1)
Glioma (Phase 2)
Head and Neck Neoplasms (Phase 1)
Heart Failure (Phase 2)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 3)
Hepatitis, Chronic (Phase 3)
Hypertension (Phase 2)
Immunologic Deficiency Syndromes (Phase 3)
Intermittent Claudication (Phase 3)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Liver Neoplasms (Phase 1)
Lymphoma (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 1)
Malaria (Phase 2)
Malaria, Falciparum (Phase 2)
Malaria, Vivax (Phase 2)
Melanoma (Phase 2)
Multiple Myeloma (Phase 1)
Muscular Atrophy (Phase 2)
Muscular Atrophy, Spinal (Phase 2)
Muscular Diseases (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 1)
Neoplasms, Connective and Soft Tissue (Phase 1)
Neoplasms, Plasma Cell (Phase 1)
Pancreatic Neoplasms (Phase 1)
Peripheral Arterial Disease (Phase 3)
Peripheral Vascular Diseases (Phase 3)
Polyneuropathies (Phase 2)
Respiratory Tract Neoplasms (Phase 1)
Severe Combined Immunodeficiency (Phase 3)
Skin Neoplasms (Phase 1)
Soft Tissue Neoplasms (Phase 1)
Spinal Muscular Atrophies of Childhood (Phase 2)
Ulcer (Phase 3)
Urogenital Neoplasms (Phase 1)
Varicose Ulcer (Phase 2)
Vascular Diseases (Phase 3)